Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,600 | 154,500 | 65,500 | -3,000 | 13,900 |
| Depreciation Amortization | 2,900 | 19,300 | 12,200 | 8,000 | 3,700 |
| Income taxes - deferred | -31,600 | 19,100 | 5,600 | -3,400 | -300 |
| Accounts receivable | -41,700 | -162,200 | -115,700 | -93,500 | -78,000 |
| Other Working Capital | -57,500 | -67,400 | -65,900 | -50,300 | -75,700 |
| Other Operating Activity | 79,300 | 376,100 | 294,700 | 239,800 | 95,900 |
| Operating Cash Flow | $-125,200 | $339,400 | $196,400 | $97,600 | $-40,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,300 | -621,200 | -387,900 | 16,200 | -7,700 |
| PPE Investments | -8,500 | -16,500 | -14,700 | -16,400 | -7,600 |
| Net Acquisitions | N/A | -42,700 | N/A | N/A | N/A |
| Purchase Of Investment | -31,300 | -7,700 | -7,700 | N/A | -192,800 |
| Sale Of Investment | N/A | 511,000 | 348,800 | N/A | 176,500 |
| Investing Cash Flow | $-42,100 | $-177,100 | $-61,500 | $-200 | $-31,600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -279,000 | -279,000 | -279,000 | N/A |
| Common Stock Issued | 8,200 | 44,700 | 20,100 | 8,700 | 6,100 |
| Financing Cash Flow | $8,200 | $-234,300 | $-258,900 | $-270,300 | $6,100 |
| Exchange Rate Effect | N/A | -1,300 | N/A | N/A | N/A |
| Beginning Cash Position | 270,700 | 344,000 | 344,000 | 344,000 | 344,000 |
| End Cash Position | 111,600 | 270,700 | 220,000 | 171,100 | 278,000 |
| Net Cash Flow | $-159,100 | $-73,300 | $-124,000 | $-172,900 | $-66,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -125,200 | 339,400 | 196,400 | 97,600 | -40,500 |
| Capital Expenditure | -8,500 | -16,500 | -14,700 | -16,400 | -7,600 |
| Free Cash Flow | -133,700 | 322,900 | 181,700 | 81,200 | -48,100 |